Skip to main content

PERFIL DE EXPRESION GENICA EN LINFOCITOS T CD4 + DE PACIENTES CON GRANULOMATOSIS EOSINOFILICA CON POLIANGEITIS O SINDROME DE CHURG-STRAUSS

PI18/00461

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2018
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre INSTITUTO DE INVESTIGACIONES BIOMEDICAS AUGUST PI I SUNYER (IDIBAPS)
Execution centre INSTITUTO DE INVESTIGACIONES BIOMEDICAS AUGUST PI I SUNYER (IDIBAPS)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status

  • Lyons, Paul A.
  • Peters, James E.
  • Alberici, Federico
  • Liley, James
  • Coulson, Richard M. R.
  • Astle, William
  • Baldini, Chiara
  • Bonatti, Francesco
  • Cid, María Cinta|||0000-0002-4730-0938
  • Elding, Heather
  • Emmi, Giacomo|||0000-0001-9575-8321
  • Epplen, Jörg
  • Guillevin, Loïc
  • Jayne, David R. W.
  • Jiang, Tao
  • Gunnarsson, Iva
  • Lamprecht, Peter
  • Leslie, Stephen
  • Little, Mark A.
  • Martorana, Davide
  • Moosig, Frank
  • Neumann, Thomas
  • Ohlsson, Sophie|||0000-0002-5253-1650
  • Quickert, Stefan
  • Ramirez, Giuseppe A.
  • Rewerska, Barbara
  • Schett, George
  • Sinico, Renato A.
  • Szczeklik, Wojciech|||0000-0002-1349-1123
  • Tesar, Vladimir|||0000-0001-6982-0689
  • Vukcevic, Damjan
  • Akil, Mohammed
  • Barratt, Jonathan
  • Basu, Neil
  • Butterworth, Adam|||0000-0002-6915-9015
  • Bruce, Ian
  • Clarkson, Michael
  • Conlon, Niall
  • DasGupta, Bhaskar
  • Doulton, Timothy W. R.
  • Espígol Frigolé, Georgina|||0000-0002-8299-0209
  • Flossmann, Oliver
  • Gabrielli, Armando
  • Gasior, Jolanta
  • Gregorini, Gina
  • Guida, Giuseppe
  • Hernández Rodríguez, José|||0000-0002-2357-2015
  • Hruskova, Zdenka
  • Hudson, Amy
  • Knight, Ann
  • Lanyon, Peter
  • Luqmani, Raashid|||0000-0002-4446-5841
  • Magliano, Malgorzata
  • Manfredi, Angelo A.
  • Marguerie, Christopher
  • Maritati, Federica
  • Marvisi, Chiara
  • McHugh, Neil J.|||0000-0003-2765-658X
  • Molloy, Eaminn
  • Motyer, Allan
  • Mukhtyar, Chetan
  • Padyukov, Leonid|||0000-0003-2950-5670
  • Pesci, Alberto
  • Prieto-Gonzalez, Sergio
  • Ramentol-Sintas, Marc
  • Reis, Petra
  • Roccatello, Dario
  • Rovere-Querini, Patrizia
  • Salvarani, Carlo|||0000-0001-5426-5133
  • Santarsia, Francesca
  • Solans, Roser|||0000-0002-0058-1293
  • Soranzo, Nicole|||0000-0003-1095-3852
  • Taylor, Jo
  • Wessels, Julie
  • Zwerina, Jochen
  • Terrier, Benjamin|||0000-0001-6612-7336
  • Watts, Richard A.
  • Vaglio, Augusto
  • Holle, Julia U.
  • Wallace, Chris
  • Smith, Kenneth G. C.
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare inflammatory disease of unknown cause. 30% of patients have anti-neutrophil cytoplasmic antibodies (ANCA) specific for myeloperoxidase (MPO). Here, we describe a genome-wide association study in 676 EGPA cases and 6809 controls, that identifies 4 EGPA-associated loci through conventional case-control analysis, and 4 additional associations through a conditional false discovery rate approach. Many variants are also associated with asthma and six are associated with eosinophil count in the general population. Through Mendelian randomisation, we show that a primary tendency to eosinophilia contributes to EGPA susceptibility. Stratification by ANCA reveals that EGPA comprises two genetically and clinically distinct syndromes. MPO+ ANCA EGPA is an eosinophilic autoimmune disease sharing certain clinical features and an HLA-DQ association with MPO+ ANCA-associated vasculitis, while ANCA-negative EGPA may instead have a mucosal/barrier dysfunction origin. Four candidate genes are targets of therapies in development, supporting their exploration in EGPA.